JAKing up resistance to immunotherapy – Science
|
JAKing up resistance to immunotherapy
Science To examine the relevance of APLNR in the in vivo setting of immunotherapy, the authors targeted the murine Aplnr gene in a B16 melanoma cells using CRISPR or RNA interference and transferred either the original or modified melanoma cells along with … |
